About Crocker Ventures
Crocker Ventures is a venture capital firm founded in 1998. It is primarily based out of Salt Lake City, United States. As of Feb 2025, Crocker Ventures has invested in 12 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to EdTech and Enterprise Applications. Most recently it participated in the $***** Series A round of Rebel Medicine Overall, Crocker Ventures portfolio has seen 1 IPO, namely Clene Nanomedicine. A lot of funds co-invest with Crocker Ventures, with names like Central Texas Angel Network sharing a substantial percentage of its portfolio. Crocker Ventures has team of 4 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio IPOs
Crocker Ventures' List of Top Investments
Crocker Ventures has a portfolio of 12 companies. Their most notable investments are in Rebel Medicine and IsoTalent.Their portfolio spans across United States and Pakistan. They have invested in Life Sciences, EdTech, Enterprise Applications and 3 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by Crocker Ventures:Biopharmaceutical company delivering life-changing medicines through targeted growth factor therapies. Focused on rescuing cells from injury, this clinical-stage company develops groundbreaking therapies designed to target and heal damaged tissues. Their Smart Growth Factor technology enables the rapid development of growth factor fusion proteins with broad applicability. The lead asset, a first-in-class, targeted fusion protein, precisely delivers cell survival functions to sites of injury. They are dedicated to selective targeting of naturally occurring growth factors to promote cell survival and growth, with a mission to deliver innovative solutions for patients in need. Their pipeline includes treatments for stroke, heart attack, and kidney injury, with ongoing Phase II studies.
Key facts about Silver Creek Pharma
- Founded Year: 2010
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $27.2M
- Employee Count: 12 as on Aug 31, 2026
- Investors: NIH, HHS and 1 Other
- Latest Funding Round: Series B, Feb 05, 2018, $*****
- Highlight: Editors' Pick
Developer of therapeutics for the treatment of neurodegenerative diseases. The company focused on revolutionizing the treatment of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Their approach centers on developing novel clean-surfaced nanotechnology therapeutics that target cellular energy impairments common in these diseases to restore and protect neuronal health and function.
Key facts about Clene Nanomedicine
- Founded Year: 2012
- Location: Salt Lake City (United States)
- Annual Revenue: $0 - $1M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $42.5M
- Employee Count: 72 as on Jun 30, 2026
- Investors: SymBiosis, KSV Global and 7 Others
- Latest Funding Round: Post IPO, Oct 01, 2024, $*****
- Highlight: Public
3. Xenocor
Provider of Laparoscopic imaging system for surgeries. The device Xenoscope is FDA 510(k) cleared K171344. The device is sterile, single-use, multi-purpose scope performs HD real-time image acquisition, facilitates use in remote and extreme environments without a power grid, aiming to transform minimally invasive laparoscopy.
Key facts about Xenocor
- Founded Year: 2000
- Location: Salt Lake City (United States)
- Stage: Early Stage
- Total Funding till date: $10M
- Employee Count: 10 as on Sep 30, 2026
- Investors: GenHenn Capital, Patel Family Investments and 2 Others
- Latest Funding Round: Unattributed, Mar 21, 2023, $*****
- Highlight: Editors' Pick
Developer of therapeutics for pain management. It offers Alevatrx injectable local anesthetic formulation for postoperative pain and Alevaderm is a local anesthetic wound dressing for painful dermal injuries.
Key facts about Rebel Medicine
- Founded Year: 2018
- Location: Salt Lake City (United States)
- Stage: Series A
- Total Funding till date: $8.79M
- Employee Count: 15 as on Aug 31, 2026
- Investors: Central Texas Angel Network, HHS and 4 Others
- Latest Funding Round: Series A, Feb 07, 2025, $*****
- Highlight: Editors' Pick
Merrimack is developing antibodies and nanoliposomes for a multifaceted attack on cancer. Its drug pipeline includes ONIVYDE (irinotecan liposome injection) for pancreatic cancer (Phase 2), breast cancer (Phase 1), pediatric sarcoma (Phase 1); MM-302, a novel antibody-drug conjugated liposomal doxorubicin that specifically targets cancer cells overexpressing the HER2 receptor for breast cancer (Phase 2), MM-121, a fully human monoclonal antibody that targets the HER3 receptor for non-small cell lung cancer (Phase 2); MM-141, a fully human monoclonal antibody that acts as a tetravalent bispecific inhibitor of IGF-1R and HER3 signaling for pancreatic cancer (Phase 2); MM-151, an oligoclonal therapeutic consisting of a mixture of 3 fully human monoclonal antibodies designed to bind and inhibit signaling of the epidermal growth factor receptor (EGFR) for advanced refractory solid tumors (Phase 1). ONIVYDE is already approved bt FDA in Oct 2015 for patients suffering from post-gemcitabine metastatic pancreatic cancer.
Key facts about Merrimack Pharmaceuticals
- Founded Year: 2000
- Location: Cambridge (United States)
- Stage: Deadpooled
- Total Funding till date: $230M
- Employee Count: 67 as on Sep 30, 2026
- Investors: Jennison, Expansion Venture Capital and 9 Others
- Latest Funding Round: Venture Debt, Jul 02, 2018, $*****
Crocker Ventures' Year-on-Year Investment Trends
Crocker Ventures has invested in 12 companies over the last 18 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Rebel Medicine and most recent follow-on round was in Merrimack Pharmaceuticals.Crocker Ventures' Investments by Stage
Crocker Ventures has made 2 investments in Series A stage with an average round size of $5.39M, 1 investment in Seed stage with an average round size of $5.15M and 1 investment in Series F stage with an average round size of $60M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Seed | 1 |
Series F | 1 |
Note: We have considered here, only first round of investments
Crocker Ventures' Investments by Sector
Crocker Ventures has a diverse portfolio, with companies operating in the Life Sciences, Business Services, EdTech and Enterprise Applications. Notably, it has invested in 11 Tech companies, 9 Enterprise (B2B) companies, 6 Software companies and at least 4 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Business Services | 1 |
EdTech | 1 |
Enterprise Applications | 1 |
Note: We have considered here, only first round of investments
Crocker Ventures' Investments by Geography
Crocker Ventures has made most investments in United States (4).Crocker Ventures' recent investments
Crocker Ventures has not made any investment in 2026 so far.Here are the most recent investments by Crocker Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 07, 2025 | United States | Series A | 5528 | ||
Aug 17, 2022 | United States | Seed | 9119 | [+1] | |
Nov 28, 2012 | United States | Series A | 9011 | - | |
Apr 11, 2011 | United States | Series G | 8202 | [+2] | |
Jun 10, 2008 | United States | Series F | 2409 | [+1] |
IPOs and Publicly Listed companies in Crocker Ventures' Portfolio
1 of Crocker Ventures' portfolio company became public - Clene Nanomedicine. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Dec 2020.Here are Crocker Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 31, 2020 | - | - | 4116 |
Team profile of Crocker Ventures
Crocker Ventures has a team of 4 members including 2 Partners located in United States. Crocker Ventures' team does not sit on the board of any company as of now.Co-investors of Crocker Ventures
Over the past 18 years, 16 investors have co-invested in Crocker Ventures's portfolio companies. This includes only funds.
- Invested before Crocker Ventures: HHS, Sorenson Capital and 5 others have invested in rounds before Crocker Ventures. There is 1 company where HHS has invested before Crocker Ventures and 1 company where Sorenson Capital has invested before Crocker Ventures.
- Top Co-investors of Crocker Ventures: 8 investors entered a company along with Crocker Ventures. These include investors like Central Texas Angel Network (1 company).
- Invested after Crocker Ventures: TPG-Axon Capital (1 company) is the only investor which has invested in Crocker Ventures's portfolio after their investments.
Recent News related to Crocker Ventures
•
Rebel Medicine Announces $6M Series A Financing to Advance Pain Therapeuticintelligence360•Jun 20, 2025•Joanandtimfoundation, Utah Innovation Fund, Rebel Medicine, Central Texas Angel Network and 2 others
•
IsoTalent Raises USD5M in Seed FundingFinSMEs•Aug 18, 2022•IsoTalent, Crocker Ventures, AD Ventures, Sweater
•
TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy PlatformGenomeWeb•May 10, 2021•Crocker Ventures, GenetronHealth, ARUP Laboratories, Nfcr
